Catabolism of lipoprotein-X induced by infusion of 10% fat emulsion

Nutrition

Volumn 13, Issue 5, 1997, Pages 417-421

  Abe, Mikio ^a   Kawano, Mikihiko ^b   Tashiro, Tsuguhiko ^b   Yamamori, Hideo ^b   Takagi, Kazuya ^b   Morishima, Yuichi ^b   Shirai, Kohji ^b   Saitou, Yasushi ^b   Nakajima, Nobuyuki ^b  

^a Awa Medical Association Hospital   (Japan)

^b NONE

Author keywords

10 Fat emulsion; Atherogenesis; Lipoprotein X

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID EMULSION; LIPOPROTEIN X; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL METABOLISM; CELL STRAIN HEPG2; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS FISTULA; ESOPHAGUS RESECTION; HUMAN; HUMAN CELL; INTESTINE ANASTOMOSIS; INTESTINE FISTULA; LIPID ANALYSIS; LIPOLYSIS; MACROPHAGE; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION;

FISTULA;

EID: 0030917168     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(97)91279-X     Document Type: Article

References (22)

1. Tashiro T, Mashima Y, Yamamori H, et al. Alteration of lipoprotein profile during total parenteral nutrition with Intralipid 10%. JPEN 1985;10:622
2. Tashiro T, Mashima Y, Yamamori H, et al. Increased Lp-X caused hyperlipidemia during intravenous administration of Intralipid 10% in man. JPEN 1991;15:546
3. Tashiro T, Mashima Y, Yamamori H, et al. Lipoprotein metabolism during total parenteral nutrition including Intralipid 10%. Jpn J Surg Metab Nutr 1985;19:57
4. Tashiro T, Mashima Y, Yamamori H, et al. Alteration of lipids composition of low density lipoprotein during total parenteral nutrition with Intralipid 10%. Jpn Surg Metab Nutr 1985;19:330
5. Tashiro T, Mashima Y, Yamamori H, et al. Intravenous Intralipid 10% vs 20%, hyperlipidemia, and increase in lipoprotein-X in humans. Nutrition 1992;8:155
6. Seidel D, Alaupovic P, Furman RH. A lipoprotein characterizing obstructive jaundice. I. method for quantitative separation and identification of lipoprotein in jaundiced subjects. J Clin Invest 1969;48:1211
7. Breckenridge WC, Kakis G, Kukis A. Identification of lipoprotein-X-like particles in rat plasma following Intralipid infusion. Can J Biochem 1979;57:72
8. Miyahara T, Fujiwara H, Yae Y, et al. Abnormal lipoprotein appearing in plasma of patients who received a ten percent soybean oil emulsion infusion. Surgery 1979;85:566
9. Griffin E, Breckenridge WC, Kukis A, et al. Appearance and characterization of lipoprotein-X during continuous Intralipid infusions in the neonate. J Clin Invest 1979;64:1703
10. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983;52:223
11. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977;46:897
12. Stein O, Stein Y. The removal of cholesterol from Landschutz ascites cells by high density apolipoprotein. Biochim Biophys Acta 1973;326:234
13. Brown MS, Dana SE, Goldstein JL. Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. Proc Natl Acad Sci USA 1975;72:2925
14. Hylemon PB, Gurley EC, Kubaska WM, et al. Suitability of primary monolayer cultures of adult rat hepatocyte for studies of cholesterol and bile acid metabolism. J Biol Chem 1985;1015
15. Lowry OH, Rosebrough NJ, Farr AF, et al. Protein measurements with the Folin phenol reagents. J Biol Chem 1951;193:265
16. Friedman M, Byers SO. Role of hyperphospholipidemia and neutral fat increase in plasma in the pathogenesis of hypercholesterolemia. Am J Physiol 1956;186:13
17. Friedman M, Byers SO, Rosenmann RH. Resolution of aortic atherosclerosis infiltration in the rabbit by phosphatide infusion. Proc Soc Exp Biol Med 1957;95:586
18. Williams KJ, Werth VP, Wolff JA. Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle. Perspect Biol Med 1984;27:417
19. Adams CWM, Abudulla YH, Bayliss OB, et al. Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intravenous injection of saturated and polysaturated lecithins. J Pathol Bacteriol 1967;94:77
20. Stafford WW, Day CE. Regression of atherosclerosis effected by intravenous phospholipid. Artery 1975;1:106
21. Untracht SH. Intravascular metabolism of an artificial transporter of triacylglycerols. Biochim Biophys Acta 1982;711:176
22. Williams KJ, Tall AR, Tabas I, et al. Recognition of vesicular lipoproteins by the apolipoprotein B, E receptor of cultured fibroblasts. J Lipid Res 1986;27:892